ACTIVE

PHARMACIE D'OTTIGNIES

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result145,5 k €+100,4 %over 1 year

Gross margin318 k €+49,6 %over 1 year

Equity344,1 k €+6,7 %over 1 year

Workforce1,5 ETP+15,4 %over 1 year

Identity

Source · BCE/KBO

PHARMACIE D'OTTIGNIES is a Public limited company incorporated in 1990. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Ottignies-Louvain-la-Neuve. It employs on average 1,5 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0442.281.693
Incorporation: 11/12/1990
Legal form: Public limited company
Registered office: Avenue Reine Astrid 24
1340 Ottignies-Louvain-la-Neuve · WallonieSee on map
Contributed capital: 81 000,00 €
Latest accounts: 31/12/2025
Average workforce: 1,5 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 20 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	318 k €	+49.6%	212,6 k €	+25.3%	169,7 k €	-26.2%	229,8 k €	-27.5%	317 k €
EBITDA	205,2 k €	+67.2%	122,8 k €	+0.9%	121,6 k €	-37.4%	194,4 k €	-11.9%	220,5 k €
Operating result	183,8 k €	+80.7%	101,7 k €	-4.5%	106,5 k €	-41.7%	182,6 k €	-13.0%	209,9 k €
Net result	145,5 k €	+100%	72,6 k €	-3.0%	74,8 k €	-42.0%	128,9 k €	-24.5%	170,6 k €
Balance sheet
Equity	344,1 k €	+6.7%	322,6 k €	+0.8%	320 k €	+1.5%	315,2 k €	+33.4%	236,3 k €
Total assets	719 k €	+12.3%	640,1 k €	-8.5%	699,7 k €	+9.2%	641 k €	+13.6%	564,1 k €
Cash	88 k €	+10.1%	79,9 k €	-33.7%	120,6 k €	-17.0%	145,3 k €	+94.8%	74,6 k €
Debts	374,7 k €	+18.0%	317,4 k €	-16.4%	379,7 k €	+16.5%	325,8 k €	+0.3%	324,9 k €
Other
Workforce	1,5 ETP	+15.4%	1,3 ETP		0,0 ETP	-100%	1,1 ETP	+83.3%	0,6 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 8 ended

Active mandates

Anne Scarnier

Director · since 07 juin 2021 · until 07 juin 2027

Active

Antoine Stil

Director · since 07 juin 2021 · until 07 juin 2027

Active

SV Pharma

Director · since 07 juin 2021 · until 07 juin 2027 · 0767.715.111

Represented by Damien VANDEN BERGHE

Active

Ended mandates

Bertrand WUIAME

Director · until 01 juin 2013

Ended

Bertrand WUIAME

Director · until 01 juin 2019

Ended

Bertrand WUIAME

Director · until 07 juin 2025

Ended

BERTRAND WUIAME

Director · until 07 juillet 2013

Ended

Other companies at this address

Avenue Reine Astrid 24 1340 Ottignies-Louvain-la-Neuve

Company	CBE no.
Associtation des copropriétaires "Avenue Reine Astrid 24" à 1340 Ottignies-Louvain-la-Neuve● Active	1030.161.477
Deep Trends Lab● Active	1017.835.648
SV Pharma● Active	0767.715.111
SV Real Estate● Active	0767.716.891

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	07/08/2026	17/07/2025	19/07/2024	03/07/2023	30/09/2022	28/06/2021
General meeting	19/06/2026	20/06/2025	21/06/2024	03/06/2023	04/06/2022	05/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	19/06/2026	07/08/2026	French	PDF
Abridged model	31/12/2024	20/06/2025	17/07/2025	French	PDF
Abridged model	31/12/2023	21/06/2024	19/07/2024	French	PDF
Abridged model	31/12/2022	03/06/2023	03/07/2023	French	PDF
Abridged model	31/12/2021	04/06/2022	30/09/2022	French	PDF
Abridged model	31/12/2020	05/06/2021	28/06/2021	French	PDF
Abridged model	31/12/2019	06/06/2020	28/08/2020	French	PDF
Abridged model	31/12/2018	01/06/2019	27/08/2019	French	PDF
Abridged model	31/12/2017	02/06/2018	27/08/2018	French	PDF
Abridged model	31/12/2016	03/06/2017	28/08/2017	French	PDF
Abridged model	31/12/2015	04/06/2016	26/08/2016	French	PDF
Abridged model	31/12/2014	06/06/2015	26/08/2015	French	PDF
Abridged model	31/12/2013	27/06/2014	27/08/2014	French	PDF
Abridged model	31/12/2012	28/06/2013	27/08/2013	French	PDF
Abridged model	31/12/2011	02/06/2012	18/07/2012	French	PDF
Abridged model	31/12/2010	04/06/2011	27/07/2011	French	PDF
Abridged model	31/12/2009	05/06/2010	30/09/2010	French	PDF
Abridged model	31/12/2008	06/06/2009	05/02/2010	French	PDF
Abridged model	31/12/2007	07/06/2008	31/07/2008	French	PDF
Abridged model	31/12/2006	02/06/2007	27/08/2007	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 8 ended

Active mandates

Anne Scarnier

Director · since 07 juin 2021 · until 07 juin 2027

Active

Antoine Stil

Director · since 07 juin 2021 · until 07 juin 2027

Active

SV Pharma

Director · since 07 juin 2021 · until 07 juin 2027 · 0767.715.111

Represented by Damien VANDEN BERGHE

Active

Ended mandates

Bertrand WUIAME

Director · until 01 juin 2013

Ended

Bertrand WUIAME

Director · until 01 juin 2019

Ended

Bertrand WUIAME

Director · until 07 juin 2025

Ended

BERTRAND WUIAME

Director · until 07 juillet 2013

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates17/10/2023
DENOMINATION - ASSEMBLEE GENERALE
PDF
Mandates21/06/2021
DEMISSIONS, NOMINATIONS
PDF
Mandates04/11/2020
DEMISSIONS, NOMINATIONS
PDF
Mandates06/09/2013
DEMISSIONS, NOMINATIONS
PDF
Other18/01/2013
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Mandates28/09/2007
DEMISSIONS, NOMINATIONS
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

2025
Annual accounts 2025145,5 k €↑
2024
Annual accounts 202472,6 k €↓
2023
Annual accounts 202374,8 k €↓
2023
Name changePharmacie d'Ottignies
2022
Annual accounts 2022128,9 k €↓
2021
Annual accounts 2021170,6 k €↑
2020
Annual accounts 202027 k €↓
2019
Annual accounts 201950,3 k €↑
2018
Annual accounts 2018-20,9 k €↓
2017
Annual accounts 2017-16,8 k €↓
2016
Annual accounts 201625,4 k €↓
2015
Annual accounts 201551,9 k €↑
2014
Annual accounts 2014-1,5 k €↑
2013
Annual accounts 2013-58 k €↓
2012
Annual accounts 2012-10,9 k €↓
2011
Annual accounts 2011-5,5 k €↑
2010
Annual accounts 2010-32 k €↑
2009
Annual accounts 2009-61,6 k €↓
2008
Annual accounts 2008-17 k €↓
2007
Annual accounts 200711,9 k €↑
2006
Annual accounts 2006-5,6 k €
2006
Name changePharmacie Schleich
11/12/1990
IncorporationPublic limited company

PHARMACIE D'OTTIGNIES

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline